Interview: Rikus Wolbers and John Schalken – Novio Tech Campus and SMB Life Sciences, The Netherlands
25.11.2015
Related Interviews
Belgium / Payer Unpacks New Medicines Roadmap
Speaking exclusively to PharmaBoardroom, Pedro Facon outlines the scope and aims of the new medicines roadmap that NIHDI has recently presented to the Belgian Ministry of Health following extensive stakeholder…
Marwa Soliman – General Manager MEA, Radiometer
Marwa Soliman of blood gas testing pioneer Radiometer explains how the company’s operations have developed in the MEA region, growing awareness of the importance of point-of-care diagnostics post-COVID, and how…
Ramy Koussa – Middle East, North Africa & Turkey (MENAT) Associated…
Ramy Koussa shares the passion and vision of focused women’s health player Organon in the MENAT region, how the organisation has adapted and improved to better serve women in the…
India / Sanofi Demerger; Junshi/Dr. Reddy's Partnership; Venus Remedies Approvals
Top stories from Indian pharma including Sanofi India’s plans to demerge its healthcare businesses; Junshi Biosciences and Dr. Reddy’s anti-PD-1 monoclonal antibody partnership; Venus Remedies’ new oncology approvals; CORONA and…
China / Eisai/Bliss Biopharma USD 2 Billion Partnership; Hasten Biopharmaceutic/Roche Deal
The latest healthcare and life sciences news from China, including Eisai’s USD 2 billion oncology deal with Bliss Biopharma; Hasten Biopharmaceutic acquisition of commercial rights in China for Rocephin from…
Belgium / 5 Pharma Industry Leaders Speak Out on Access Issues
Despite the thriving life sciences ecosystem that has made Belgium one of the top European destinations for clinical trials, the country continues to grapple with considerable access challenges and remains…
